HAIXI PHARMA (02637) has announced that Dr. Chen Shuyi and Mr. Gong Weimin have retired as directors of the board following the conclusion of the annual general meeting.

During the annual general meeting, Mr. Li Junqing was elected as an executive director, and Mr. Lin Bin was elected as an independent non-executive director. Their terms are for three years, effective from the end of the annual general meeting until the conclusion of the company's annual general meeting in 2029.

At a subsequent board meeting, the board elected Kang Xinshan as the chairman of the second-term board of directors for a three-year term, commencing from the date of the board meeting.

Additionally, the board appointed Kang Xinshan as the company's general manager. Other appointments include Ms. Feng Yan as deputy general manager, Dr. Chen Guangming as deputy general manager, Dr. Zhang Mingqiang as deputy general manager, and Ms. Zhang Junhuan as board secretary and chief financial officer.